Elixinol Wellness (AU:EXL) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Elixinol Wellness Limited has announced a change in the interests of its director, David Fenlon, following a capital consolidation where every 8 securities were consolidated into 1. This move, approved in the recent Extraordinary General Meeting, has adjusted Fenlon’s holdings to 625,294 fully paid ordinary shares and various performance rights and options.
For further insights into AU:EXL stock, check out TipRanks’ Stock Analysis page.
